Row SystemWave Shape Decorative svg added to bottom Resource Library Find supporting resources for our platform. Filter by Resource TypeApplication NoteBrochureFlyerPosterPrimary LiteratureTechnical NoteVideoWebinarWhite Paper Open Filter Webinar Webinar: Gene to Grid in Four Days: Cell-Free GPCRs for Cryo-EM Join Dr Dima Chirgadze (University of Cambridge) and Dr Thomas Guilliam (Nuclera) as they explore how a collaborative study brought together cell-free protein synthesis and cryo-EM to address these challenges. Discover how direct synthesis into defined lipid nanodiscs, combined with construct and membrane-condition screening using the eProtein Discoveryâ„¢ system, provided a route to producing GPCRs… Webinar Data-Driven Epitope-Specific Antibody Design and Rapid SpyBLI Validation Discover how data-driven approaches enable epitope-specific antibody design and how SpyBLI delivers quantitative binding kinetics directly from crude samples, without purification. Primary Literature New preprint: GPCR Cryo-EM in Four Days Using Cell-Free Synthesis Discover how cell-free protein synthesis, lipid nanodiscs and eProtein Discoveryâ„¢ screening combined to achieve a 3.38 Ã… GPCR cryo-EM structure, with just four days from gene assembly to grid vitrification. The paper also demonstrates detergent-free production of 12 additional GPCRs across Classes A–C, including six orphan receptors. Webinar Webinar: The Missing Triage Step in AI Antibody Hit Validation Give AI antibody discovery the triage step it’s missing. Filter out non-binders before high-cost downstream validation. Webinar Webinar: AI Antibody Discovery: From Model to Molecule See how computational models and rapid full-length IgG testing work together to close the Design-Build-Test-Learn loop. White Paper White Paper: Cell-Free Antibodies Predict CHO Binding Kinetics This white paper presents a head-to-head validation dataset showing that an engineered E. coli cell-free protein synthesis (CFPS) system produces full-length IgG1 antibodies whose early binding readouts closely track CHO-made controls. The goal isn’t to replace CHO — it’s to establish CFPS as a reliable triage step before every candidate is committed to mammalian expression,… White Paper White Paper: AI Antibody Library Screening: Rapid Cell-Free Triage Before CHO Scale-Up Validating thousands of AI-generated antibody variants in slow mammalian workflows creates a massive bottleneck. This white paper introduces an automated, 96-plex cell-free protein synthesis (CFPS) triage step prior to CHO scale-up. A 14-day sequence-to-decision workflow achieved 99% full-length IgG expression across 188 AI variants and successfully diverted 139 non-binders from costly validation. Delivering up to… Poster Poster: Rapid Cell-Free Validation of AI-Generated Antibody Libraries in 14 Days Relying on slow, capacity-limited mammalian expression to assess hundreds of antibody sequences creates a 4-to-5-week validation bottleneck. This featured poster introduces an engineered E. coli cell-free protein synthesis (CFPS) workflow to rapidly triage out non-binders before committing to costly biology. The system successfully produces full-length, fully assembled antibodies with proper disulfide bonds at screening-relevant yields.… Webinar Webinar: The Missing Triage Step in AI Antibody Hit Validation AI models are generating thousands of promising antibody variants faster than ever before. But because downstream mammalian expression and SPR validation are high-cost and time-consuming, teams are forced into a costly bottleneck—often over-investing in candidates that simply do not bind. Join Stacey Willard, Vice President of Marketing and Product Management at Nuclera, for insights into… Webinar Cell-Free Protein Screening to Predict Scale-Up Success Join Dr. Magdalena Richter, Associate Principal Scientist at AstraZeneca, as she details how her team systematically addressed this bottleneck. By benchmarking Nuclera’s eProtein Discoveryâ„¢ system against standard E. coli cell-based expression, her team asked a critical question: Can a 24-hour, cell-free screen accurately predict expression success at scale? Pages: 1234567Load More Resources